Heska Corp (HSKA) 27.93 $HSKA
Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success
ACCESSWIRE - Tue Apr 14, 8:15AM CDT
WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD"
- the non-psychoactive component of the cannabis plant - could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ: GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be possible using natural phytocannabinoids.
VSI: 44.50 (+5.54), AMZN: 389.80 (-1.38), CARA: 12.98 (+0.15), HSKA: 27.93 (+1.05), PETS: 17.11 (+0.13), GWPH: 113.04 (-0.05), GNC: 47.56 (+1.60), WOOF: 55.13 (-0.18)
Nasdaq stocks posting largest percentage increases
AP - Fri Mar 06, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
FNSR: 21.29 (-0.16), DMND: 30.74 (+0.01), HSKA: 27.93 (+1.05), ICEL: 16.47 (-0.02), LJPC: 23.04 (+1.22), ANTH: 4.79 (+0.10), RTRX: 24.45 (+0.09), CLDN: 13.59 (-2.77), EXAS: 22.28 (+0.24)
Heska misses 4Q profit forecasts
Automated Insights - Thu Mar 05, 9:39AM CST
LOVELAND, Colo. (AP) _ Heska Corp. (HSKA) on Thursday reported fourth-quarter earnings of $829,000.
HSKA: 27.93 (+1.05)
Track What Biological Products Companies Are Up To: Special Research on Gilead, Halozyme, Heska, Idera, and Kite Pharma
PR Newswire - Tue Feb 17, 7:50AM CST
Editor Note: For more information about this release, please scroll to bottom.
HALO: 16.03 (+0.15), IDRA: 3.36 (-0.02), HSKA: 27.93 (+1.05), KITE: 57.56 (-1.43), GILD: 104.18 (-1.02)
Heska Corporation (HSKA) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:32AM CST
Heska Corporation (HSKA) was a big mover last session, as the company saw its shares rise more than 7% on the day.
HSKA: 27.93 (+1.05), OPHT: 52.35 (+1.09)
Heska (HSKA) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 7:00AM CST
Heska (HSKA) Shares March Higher, Can It Continue?
HSKA: 27.93 (+1.05)
Heska Signs Distribution Agreement with scil animal care company
PR Newswire - Thu Jan 29, 8:00AM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company", a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today a new distribution agreement with the Canadian unit ("scil animal care company Canada" of scil animal care company, a companion animal health distribution company serving Canada, the United States and Europe. scil animal care company Canada will market and promote Heska's full line of hematology, blood gas & electrolytes and chemistry instruments and affiliated consumables, effective immediately.
HSKA: 27.93 (+1.05)
Bonnie Trowbridge, CPA, Joins Heska's Board of Directors
PR Newswire - Wed Jan 28, 8:00AM CST
Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company", a leading provider of veterinary diagnostic and specialty products, announced today that Bonnie J. Trowbridge, CPA, has joined Heska's Board of Directors, adding a wealth of financial expertise to the board.
HSKA: 27.93 (+1.05)
Announcing This Week's Outstanding Performance Award Winners - BuyTheDip SellTheRip And Illuminati Investments
SA Editor Daniel Shvartsman - Seeking Alpha - Mon Jan 05, 4:00AM CST
Dear readers, We're kicking off 2015 with a couple ideas that played out fantastically in 2014 and are worthy Outstanding Performance award winners. One was a long idea from 2013 that called for a double in 2014, a move that indeed played out....
HSKA: 27.93 (+1.05), CONN: 30.39 (+0.40)
Heska to Present at Sidoti Emerging Growth Institutional Investor Forum
PR Newswire - Tue Dec 30, 3:01PM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company", a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today Dr. Robert Grieve, Executive Chair, will present at The Sidoti Company, LLC's 2015 Emerging Growth Institutional Investor Forum on Monday, January 12, 2015. The company's group presentation is scheduled for 8 a.m. (ET) in Estate 3 and management will be available throughout the day for one-on-one meetings. Please email hska@haydenir.com or contact your Sidoti representative to schedule a one-on-one meeting.
HSKA: 27.93 (+1.05)
Can The Uptrend Continue for Heska (HSKA)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 8:49AM CST
Can The Uptrend Continue for Heska (HSKA)?
HSKA: 27.93 (+1.05)
One Stock Chart Trick You Should All Know - Investment Ideas
David Bartosiak - ZACKS - Tue Dec 16, 12:00AM CST
One Stock Chart Trick You Should All Know - Investment Ideas
HSKA: 27.93 (+1.05), ANIP: 69.79 (+1.24), SCMP: 21.75 (+0.47)
Heska to Attend Benchmark Micro Cap Discovery Conference
PR Newswire - Tue Nov 25, 3:01PM CST
Heska Corporation (NASDAQ: HSKA) - (News; "Heska" or the "Company", a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today Dr. Robert Grieve, Executive Chair, will attend The Benchmark Company, LLC's Micro Cap Discovery Conference on Thursday, December 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe Street, Chicago, IL from 8 a.m. to 2:30 p.m. Please email hska@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting.
HSKA: 27.93 (+1.05)
Why Intercept Pharmaceuticals (ICPT) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:40AM CST
Intercept Pharmaceuticals has witnessed a significant price decline in the past four weeks and negative earnings estimate revisions for the current quarter and the current year, making it time for investors to sell it off
HSKA: 27.93 (+1.05), ICPT: 280.45 (-8.26), AMAG: 57.68 (+0.47), DYAX: 28.12 (+0.15)
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 4:20PM CST
On Nov 21, Zacks Investment Research upgraded Illumina Inc. (ILMN) to a Zacks Rank #1 (Strong Buy).
BIIB: 423.57 (+1.46), HSKA: 27.93 (+1.05), ILMN: 190.04 (-9.27), AFFX: 12.57 (-0.13)
Heska analyst day leaves Feltl bullish
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 2:45PM CST
HSKA: 27.93 (+1.05), ABAX: 63.25 (-0.09), IDXX: 155.97 (+0.75)
Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 27.93 (+1.05), ACHN: 10.01 (-0.13), ILMN: 190.04 (-9.27), AFFX: 12.57 (-0.13)
Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success
ACCESSWIRE - Tue Apr 14, 8:15AM CDT
WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD"
- the non-psychoactive component of the cannabis plant - could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ: GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be possible using natural phytocannabinoids. VSI: 44.50 (+5.54), AMZN: 389.80 (-1.38), CARA: 12.98 (+0.15), HSKA: 27.93 (+1.05), PETS: 17.11 (+0.13), GWPH: 113.04 (-0.05), GNC: 47.56 (+1.60), WOOF: 55.13 (-0.18)
Nasdaq stocks posting largest percentage increases
AP - Fri Mar 06, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
FNSR: 21.29 (-0.16), DMND: 30.74 (+0.01), HSKA: 27.93 (+1.05), ICEL: 16.47 (-0.02), LJPC: 23.04 (+1.22), ANTH: 4.79 (+0.10), RTRX: 24.45 (+0.09), CLDN: 13.59 (-2.77), EXAS: 22.28 (+0.24)
Heska misses 4Q profit forecasts
Automated Insights - Thu Mar 05, 9:39AM CST
LOVELAND, Colo. (AP) _ Heska Corp. (HSKA) on Thursday reported fourth-quarter earnings of $829,000.
HSKA: 27.93 (+1.05)
Track What Biological Products Companies Are Up To: Special Research on Gilead, Halozyme, Heska, Idera, and Kite Pharma
PR Newswire - Tue Feb 17, 7:50AM CST
Editor Note: For more information about this release, please scroll to bottom.
HALO: 16.03 (+0.15), IDRA: 3.36 (-0.02), HSKA: 27.93 (+1.05), KITE: 57.56 (-1.43), GILD: 104.18 (-1.02)
Heska Corporation (HSKA) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:32AM CST
Heska Corporation (HSKA) was a big mover last session, as the company saw its shares rise more than 7% on the day.
HSKA: 27.93 (+1.05), OPHT: 52.35 (+1.09)
Heska (HSKA) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 7:00AM CST
Heska (HSKA) Shares March Higher, Can It Continue?
HSKA: 27.93 (+1.05)
Heska Signs Distribution Agreement with scil animal care company
PR Newswire - Thu Jan 29, 8:00AM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today a new distribution agreement with the Canadian unit ("scil animal care company Canada" of scil animal care company, a companion animal health distribution company serving Canada, the United States and Europe. scil animal care company Canada will market and promote Heska's full line of hematology, blood gas & electrolytes and chemistry instruments and affiliated consumables, effective immediately. HSKA: 27.93 (+1.05)
Bonnie Trowbridge, CPA, Joins Heska's Board of Directors
PR Newswire - Wed Jan 28, 8:00AM CST
Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"
, a leading provider of veterinary diagnostic and specialty products, announced today that Bonnie J. Trowbridge, CPA, has joined Heska's Board of Directors, adding a wealth of financial expertise to the board. HSKA: 27.93 (+1.05)
Announcing This Week's Outstanding Performance Award Winners - BuyTheDip SellTheRip And Illuminati Investments
SA Editor Daniel Shvartsman - Seeking Alpha - Mon Jan 05, 4:00AM CST
Dear readers, We're kicking off 2015 with a couple ideas that played out fantastically in 2014 and are worthy Outstanding Performance award winners. One was a long idea from 2013 that called for a double in 2014, a move that indeed played out....
HSKA: 27.93 (+1.05), CONN: 30.39 (+0.40)
Heska to Present at Sidoti Emerging Growth Institutional Investor Forum
PR Newswire - Tue Dec 30, 3:01PM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today Dr. Robert Grieve, Executive Chair, will present at The Sidoti Company, LLC's 2015 Emerging Growth Institutional Investor Forum on Monday, January 12, 2015. The company's group presentation is scheduled for 8 a.m. (ET) in Estate 3 and management will be available throughout the day for one-on-one meetings. Please email hska@haydenir.com or contact your Sidoti representative to schedule a one-on-one meeting. HSKA: 27.93 (+1.05)
Can The Uptrend Continue for Heska (HSKA)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 8:49AM CST
Can The Uptrend Continue for Heska (HSKA)?
HSKA: 27.93 (+1.05)
One Stock Chart Trick You Should All Know - Investment Ideas
David Bartosiak - ZACKS - Tue Dec 16, 12:00AM CST
One Stock Chart Trick You Should All Know - Investment Ideas
HSKA: 27.93 (+1.05), ANIP: 69.79 (+1.24), SCMP: 21.75 (+0.47)
Heska to Attend Benchmark Micro Cap Discovery Conference
PR Newswire - Tue Nov 25, 3:01PM CST
Heska Corporation (NASDAQ: HSKA) - (News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today Dr. Robert Grieve, Executive Chair, will attend The Benchmark Company, LLC's Micro Cap Discovery Conference on Thursday, December 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe Street, Chicago, IL from 8 a.m. to 2:30 p.m. Please email hska@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting. HSKA: 27.93 (+1.05)
Why Intercept Pharmaceuticals (ICPT) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:40AM CST
Intercept Pharmaceuticals has witnessed a significant price decline in the past four weeks and negative earnings estimate revisions for the current quarter and the current year, making it time for investors to sell it off
HSKA: 27.93 (+1.05), ICPT: 280.45 (-8.26), AMAG: 57.68 (+0.47), DYAX: 28.12 (+0.15)
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 4:20PM CST
On Nov 21, Zacks Investment Research upgraded Illumina Inc. (ILMN) to a Zacks Rank #1 (Strong Buy).
BIIB: 423.57 (+1.46), HSKA: 27.93 (+1.05), ILMN: 190.04 (-9.27), AFFX: 12.57 (-0.13)
Heska analyst day leaves Feltl bullish
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 2:45PM CST
HSKA: 27.93 (+1.05), ABAX: 63.25 (-0.09), IDXX: 155.97 (+0.75)
Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 27.93 (+1.05), ACHN: 10.01 (-0.13), ILMN: 190.04 (-9.27), AFFX: 12.57 (-0.13)
